avidity;
viral clearance;
CD8(+);
T cells;
tumors;
regulation;
D O I:
10.1385/IR:31:1:13
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The primary goal of vaccination is the establishment of protective immunity. Thus there has been significant effort put toward the identification of attributes of the immune response that are associated with optimal protection. Although the number of virus-specific cells elicited is unquestionably important, recent studies have identified an additional parameter, functional avidity, as critical in determining the efficiency of viral clearance. T-cell avidity is a measure of the sensitivity of a cell to peptide antigen. High-avidity cells are those that can recognize antigen-presenting cells (APC) bearing very low levels of peptide antigen, whereas low-avidity cells require much higher numbers of peptide major histocompatibility complex (MHC) complexes in order to become activated or exert effector function. We are only now beginning to gain insights into the molecular control of avidity and the signals required for the optimal activation, expansion, and retention of high-avidity cells in vivo. This review summarizes the current knowledge regarding CD8(+) T-cell avidity and explores some of the important issues that are, as of yet, unresolved.
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Appay, V
;
Nixon, DF
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Nixon, DF
;
Donahoe, SM
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Donahoe, SM
;
Gillespie, GMA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Gillespie, GMA
;
Dong, T
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Dong, T
;
King, A
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
King, A
;
Ogg, GS
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Ogg, GS
;
Spiegel, HML
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Spiegel, HML
;
Conlon, C
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Conlon, C
;
Spina, CA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Spina, CA
;
Havlir, DV
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Havlir, DV
;
Richman, DD
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Richman, DD
;
Waters, A
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Waters, A
;
Easterbrook, P
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Easterbrook, P
;
McMichael, AJ
论文数: 0引用数: 0
h-index: 0
机构:
John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
McMichael, AJ
;
Rowland-Jones, SL
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Appay, V
;
Nixon, DF
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Nixon, DF
;
Donahoe, SM
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Donahoe, SM
;
Gillespie, GMA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Gillespie, GMA
;
Dong, T
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Dong, T
;
King, A
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
King, A
;
Ogg, GS
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Ogg, GS
;
Spiegel, HML
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Spiegel, HML
;
Conlon, C
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Conlon, C
;
Spina, CA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Spina, CA
;
Havlir, DV
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Havlir, DV
;
Richman, DD
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Richman, DD
;
Waters, A
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Waters, A
;
Easterbrook, P
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
Easterbrook, P
;
McMichael, AJ
论文数: 0引用数: 0
h-index: 0
机构:
John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England
McMichael, AJ
;
Rowland-Jones, SL
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, MRC, Human Immunol Unit, Inst Mol Med, Oxford OX3 9DS, England